Drug Intelligence: Bridging clinical practice data to meaningful commercial value
Drug Intelligence data reporting is designed to answer context-specific questions from market research, marketing, and market access teams engaged in a competitive, challenging, and expanding market landscape.
Through a holistic picture, our data provides the highest level of clarity in actionable disease information, patient segmentation, treatment pathways, influencers to critical success factors and outcomes on multi-variant drug treatments.
Superior Analytics Based on Our Real-World Evidence
Real practice patterns & in-depth patient cases combined with a wide variety of secondary & primary market research data sources allows Drug Intelligence to provide the most comprehensive deep dive analytics in the industry.
Our team possesses both medical/clinical and industry expertise in primary care and specialty areas. Our ability to interpret clinical data to tangible commercial relevance provides a superior level of context & insights in the reports we deliver.
Patient Pathways and Opportunities
We provide a detailed understanding of the patient & health system pathway spanning the continuum of care from diagnosis throughout additional sequential therapy.
Leverage our data trends to anticipate marketplace shifts, plan strategy and build forecasts accordingly.